Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. (February 2017)

Record Type:
Journal Article
Title:
Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. (February 2017)
Main Title:
Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study
Authors:
Giordano, G.
Lo Re, G.
Milella, M.
Di Marco, M.
Melisi, D.
Passardi, A.
Iop, A.
Febbraro, A.
Foltran, L.
Francesca, B.
Bertocchi, P.
Vaccaro, V.
Aloi, M.B.
Giommoni, E.
Ricci, V.
Vasile, E.
Zaniboni, A.
Zagone, V.
De Vita, F.
Abstract:
Is Part Of:
European journal of cancer. Volume 72(2017)Supplement 1
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Issue Display:
Volume 72, Issue 1 (2017)
Year:
2017
Volume:
72
Issue:
1
Issue Sort Value:
2017-0072-0001-0000
Page Start:
S87
Page End:
Publication Date:
2017-02
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(17)30366-0 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
97.xml